New Rhein Healthcare Investors
Philadelphia, PA, United States · Series B → Growth
Their stated focus (public profile)
New Rhein Healthcare Investors applies a private equity approach to life sciences venture capital, focusing on later-stage, de-risked assets with proven clinical safety and efficacy. The firm takes significant stakes in a small number of companies and actively manages value creation across R&D, commercialization, and M&A. It invests broadly across therapeutic areas with a goal of delivering health benefits to patients, economic value to payors, and capital gains through strategic exits.
Stages: Series B → Growth
Sectors: Life sciences, Medtech, Drug, Bph, Cdmo, Inhalation
On file: 11 companies on record
Website: newrhein.com
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Is this your fund? Request a correction or removal.
Search the funds we have on file
Looking for investors? Search the funds we have on file — what they back, where they are, and whether your raise fits. Sign in and Percy matches you to the right ones.
Looking to claim your own fund? Start here →
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Funds closest to this thesis
Ordered by how close each thesis sits to this one.
Is this your fund? Request a correction or removal.